Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 2, pp. 178-188
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 22, 2017
- Revision received July 17, 2017
- Accepted November 30, 2017
- Published first December 7, 2017.
Article Versions
- Previous version (December 7, 2017 - 06:33).
- Previous version (January 23, 2018 - 07:28).
- You are viewing the most recent version of this article.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Chunlin Li1,2,
- Nengpan Zhang1,
- Jundong Zhou3,
- Chen Ding1,4,
- Yaqing Jin1,2,
- Xueyuan Cui1,5,
- Kefeng Pu1, and
- Yimin Zhu1,*
- 1CAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, China.
- 2University of Chinese Academy of Sciences, Beijing, China.
- 3Nanjing Medical University, Affiliated Suzhou Hospital, Department Radio Oncology, Suzhou, China.
- 4China Pharmaceutical University, Nanjing, China.
- 5Shanghai University, Shanghai, China.
- ↵*Corresponding Author:
Yimin Zhu, Suzhou Institute of Nano-Tech and Nano-Bionics, 398 Ruoshui Road, Suzhou Industrial Park, Suzhou 215123, China. Phone: 8605-12628-72618; Fax: 8605-12628-72553; E-mail: ymzhu2008{at}sinano.ac.cn
February 2018
Volume 6, Issue 2
Volume 6, Issue 2
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Jump to section
Advertisement